Active Biotech AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was SEK 10.6 million compared to SEK 13.4 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.06 a year ago. Diluted loss per share from continuing operations was SEK 0.04 compared to SEK 0.06 a year ago.
For the nine months, net loss was SEK 33.3 million compared to SEK 43.4 million a year ago. Basic loss per share from continuing operations was SEK 0.13 compared to SEK 0.19 a year ago. Diluted loss per share from continuing operations was SEK 0.13 compared to SEK 0.19 a year ago.